The role of lymph node resection in ovarian cancer: Analysis of the surveillance, epidemiology, and end results (SEER) database

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 12, 2010, Pages 1451-1458

  Rouzier, R ^a,b   Bergzoll, C ^a   Brun, J L ^c   Dubernard, G ^a   Selle, F ^a   Uzan, S ^a,b   Pomel, C ^d   DaraI E ^a,b  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c HÔPITAL PELLEGRIN   (France)

^d CENTRE JEAN PERRIN   (France)

Author keywords

Cancer; lymphadenectomy; ovary; staging; therapeutic role

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL EVALUATION; DISEASE SEVERITY; FACTUAL DATABASE; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVEILLANCE EPIDEMIOLOGY AND END RESULT; TREATMENT OUTCOME;

FEMALE; FRANCE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 78349245615     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02633.x     Document Type: Article

References (17)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, etal. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8 - 29.
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ,. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248 - 59.
3. Piver MS, Rose PG, Freedman MF,. Change in International Federation of Gynecology and Obstetrics staging. Am J Obstet Gynecol 1988; 158: 678 - 9.
4. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E,. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 1995; 56: 328 - 37.
5. Burghardt E, Pickel H, Lahousen M, Stettner H,. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986; 155: 315 - 9.
6. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, etal. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005; 97: 560 - 6.
7. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, etal. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer 2007; 96: 1817 - 22.
8. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, etal. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 2007; 109: 12 - 9.
9. Eisenkop SM, Spirtos NM,. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol Oncol 2001; 82: 143 - 9.
10. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, etal. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 1997; 65: 467 - 72.
11. Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, etal. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003; 197: 198 - 205.
12. Maggioni A, Benedetti Panici P, DellAnna T, Landoni F, Lissoni A, Pellegrino A, etal. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 2006; 95: 699 - 704.
13. Crawford SC, Vasey PA, Paul J, Hay A, Davis JA, Kaye SB,. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial J Clin Oncol 2005; 23: 8802 - 11.
14. Sugarbaker PH, Jablonski K,. Prognostic features of 51 colorectal and 130 appendiceal cancers with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124 - 32.
15. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S,. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003; 90: 390 - 6.
16. Aletti GD, Dowdy SC, Podratz KC, Cliby WA,. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 2007; 197: 676.e1 - 7.
17. Chéreau E, Ballester M, Selle F, Cortez A, DaraÏ E, Rouzier R,. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol 2010; 202: 178.e1 - 10.